Medical provider stigma experienced by people who use drugs (MPS-PWUD): Development and validation of a scale among people who currently inject drugs in New York City
- PMID: 33621804
- PMCID: PMC8029599
- DOI: 10.1016/j.drugalcdep.2021.108589
Medical provider stigma experienced by people who use drugs (MPS-PWUD): Development and validation of a scale among people who currently inject drugs in New York City
Abstract
Background: Stigmatizing attitudes towards people who use drugs (PWUD) impact their access and retention in health care. Current measures of PWUD stigma in medical settings are limited. Therefore, we developed and validated theMedical Provider Stigma Experienced by PWUD (MPS-PWUD) scale.
Methods: As part of an ongoing clinical trial, we recruited HCV RNA positive people who inject drugs in New York City. Based on 164 participants, principal component analysis (PCA) was conducted on fifteen stigma items answered on a 5-point Likert scale. We evaluated internal consistency using Cronbach's alpha coefficient and assessed construct validity by comparing stigma levels with willingness to communicate health concerns with medical providers and likelihood to seek HCV treatment.
Results: PCA identified a 9-item scale with two components of stigmatization that explained 60.8 % of the total variance and overall high internal consistency (alpha = 0.90). Theenacted stigma (alpha = 0.90) consisted of 6 scale items related to the medical providers' stigmatizing actions or perceptions. The internalized stigma component (alpha = 0.84) included 3 scale items related to PWUD's shame or drug use disclosure. As hypothesized, higher levels of either stigma were associated with less likelihood to openly communicate with medical providers (p < 0.005). Participants with a higher level of enacted stigma were less likely to seek HCV treatment (p = 0.011).
Conclusions: The validated MPS-PWUD scale could help healthcare providers, harm reduction services and researchers measure stigma experienced by PWUD in medical settings in efforts to minimize the impact of stigma on limiting access to and retention of care for PWUD.
Keywords: People who use drugs; Stigma in medical settings; Stigma scale.
Published by Elsevier B.V.
Conflict of interest statement
Author Disclosures:
Conflict of Interest
No conflict declared.
Figures
Similar articles
-
Development, validation, and potential applications of the hepatitis C virus injection-risk knowledge scale (HCV-IRKS) among young opioid users in New York City.Drug Alcohol Depend. 2019 Jan 1;194:453-459. doi: 10.1016/j.drugalcdep.2018.11.010. Epub 2018 Nov 28. Drug Alcohol Depend. 2019. PMID: 30503906 Free PMC article.
-
"They look at us like junkies": influences of drug use stigma on the healthcare engagement of people who inject drugs in New York City.Harm Reduct J. 2020 Jul 31;17(1):53. doi: 10.1186/s12954-020-00399-8. Harm Reduct J. 2020. PMID: 32736624 Free PMC article.
-
Assessing stigma: Health and social worker regard towards working with people using illicit drugs in Athens, Greece.Harm Reduct J. 2024 Sep 26;21(1):175. doi: 10.1186/s12954-024-01091-x. Harm Reduct J. 2024. PMID: 39327583 Free PMC article.
-
Questionnaires on stigmatizing attitudes among healthcare students in Taiwan: development and validation.BMC Med Educ. 2020 Feb 27;20(1):59. doi: 10.1186/s12909-020-1976-1. BMC Med Educ. 2020. PMID: 32106850 Free PMC article. Review.
-
Health care provider attitudes and beliefs about people living with HIV: Initial validation of the Health Care Provider HIV/AIDS Stigma Scale (HPASS).AIDS Behav. 2014 Dec;18(12):2397-408. doi: 10.1007/s10461-014-0834-8. AIDS Behav. 2014. PMID: 24965675 Review.
Cited by
-
What's in a Name? Terminology Preferences Among Patients Receiving Methadone Treatment.J Gen Intern Med. 2023 Feb;38(3):653-660. doi: 10.1007/s11606-022-07813-w. Epub 2022 Sep 26. J Gen Intern Med. 2023. PMID: 36163526 Free PMC article.
-
Non-financial barriers in oral health care: a qualitative study of patients receiving opioid maintenance treatment and professionals' experiences.Subst Abuse Treat Prev Policy. 2021 May 17;16(1):44. doi: 10.1186/s13011-021-00379-6. Subst Abuse Treat Prev Policy. 2021. PMID: 34001202 Free PMC article.
-
Posttraumatic stress disorder in people who use drugs: syringe services program utilization, treatment need, and preferences for onsite mental health care.Harm Reduct J. 2024 Jun 1;21(1):108. doi: 10.1186/s12954-024-01019-5. Harm Reduct J. 2024. PMID: 38824597 Free PMC article.
-
Accessible Hepatitis C Care for People Who Inject Drugs: A Randomized Clinical Trial.JAMA Intern Med. 2022 May 1;182(5):494-502. doi: 10.1001/jamainternmed.2022.0170. JAMA Intern Med. 2022. PMID: 35285851 Free PMC article. Clinical Trial.
-
Providers' knowledge and perception of xylazine in the unregulated drug supply: a sequential explanatory mixed-methods study.Harm Reduct J. 2024 Aug 16;21(1):148. doi: 10.1186/s12954-024-01052-4. Harm Reduct J. 2024. PMID: 39148036 Free PMC article.
References
-
- Boerekamps A, Newsum AM, Smit C, Arends JE, Richter C, Reiss P, 2018. High treatment uptake in human immunodeficiency virus/Hepatitis C virus-coinfected patients after unrestricted access to direct-acting antivirals in the Netherlands. Clin. Infect. Dis 66, 1352–1359. 10.1093/cid/cix1004 - DOI - PubMed
-
- Brickman P, Rabinowitz VC, Karuza JJ, Coates D, Cohn E, Kidder L, 1982. Models of helping and coping. Am. Psychol 37, 368–384. 10.1037/0003-066X.37.4.368 - DOI
-
- Clark M, 2011. Conceptualizing Addiction: How Useful Is the Construct? Int. J. Humanit. Soc. Sci 1, 55–64.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials